Top 15 Biotechnology VC (Venture Capital) Funds in Hungary in January 2025
A list of 15 VC (Venture Capital) funds that invest in Biotechnology startups based in Hungary. We rank investors based on the number of investments they made in Biotechnology companies from Hungary. We update this investor list every month.Top 15 Biotechnology VC (Venture Capital) Funds in Hungary in January 2025
Investor | Biotechnology Hungary investments |
---|---|
FastVentures | 4 |
Delin Ventures | 4 |
Accel | 3 |
Atlantic Labs | 3 |
XTX Ventures | 3 |
O2h Ventures | 3 |
Boston Millennia Partners | 2 |
PortfoLion Capital Partners | 2 |
Bonitás Ventures | 2 |
Euroventures | 2 |
Merck Global Health Innovation Fund | 1 |
MassMutual Ventures | 1 |
Texas HALO Fund | 1 |
Mercia Fund Managers | 1 |
Societe Generale Asset Management | 1 |
venture capital
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Series B
- Hungary, South Korea, United States
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
We are partnering with remarkable entrepreneurs and scientists on the mission of our lives: elevating humanity.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Seed, Series A, Series B
- United Kingdom, Hungary, United States
Portfolio highlights
- Umedeor — uMed combines RWE with the power of patient generated data to address the evidence gaps in life science research
- Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
- Ori Biotech — Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process developmentto commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.
First partner to exceptional teams everywhere
Show more
Investment focus
- Software, SaaS, Information Technology
- Series A, Series B, Series C
- United States, India, United Kingdom
Portfolio highlights
- Nuitée — Nuitée provides infrastructure APIs tailored for the travel sector, offering a user-friendly solution to transform hotel connectivity and distribution. Its technology platform serves as a vital link between accommodation providers and demand partners. The business started with a simple API and white-label solution that enables businesses and brandsto offer a comprehensive hotel booking system. Today Nuitée is a multi-product ecosystem that allows businesses to create their own booking apps, monetize their audience, and establish ongoing revenue streams while retaining full control over their brand and pricing. Founded in 2017, Nuitée is headquartered in Ireland.
- FirstClub — FirstClub's mission is to become a rapid commerce-first omnichannel retailer that uses offline experience stores to promote the quality of its items. FirstClub's goal is to create a platform that serves customers and offers brands a unique opportunity to connect with affluent homes.
- RapidCanvas — Delivering industry benchmarked out-of-the-box AI solutions that can be easily customized by business users using conversational interface.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Pre-Seed, Series A
- Germany, Switzerland, United States
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- Mago — Mago is an AI-native, fully controllable tool revolutionizing video production through style transfer. We empower creators to transform and stylize any video - from live-action to 3D animations - into any aesthetic, seamlessly blending cutting-edge AI with human creativity from concept to final cut.
- LEVY Health — Endometriosis is a condition where tissue like your uterine lining grows outside the womb: on the ovaries, fallopian tubes, pelvic tissues, or more rarely, in other parts of the body.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance
those businesses. We are geographyand industry agnostic.
Show more
Investment focus
- Artificial Intelligence, Software, Machine Learning
- Series A, Seed, Funding Round
- United Kingdom, United States, Israel
Portfolio highlights
- iGent — iGent AI focus on integrating advanced AI capabilities into the software development process.
- Verax AI — Seeks to be the leading provider of enterprise-grade trust solutions for Generative AI, enabling companies worldwide to build or adopt any Generative AI agent with confidence
- Oriole Networks — At Oriole Networks, we are pioneering the use of optical switching to create the fastest and most energy-efficient network. This innovative approach is accelerating the next generation of machine learning in high-performance computers and data centres, promising exciting possibilities for the future.
Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Seed, Series A, Pre-Seed
- United Kingdom, Hungary
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- ViaNautis — Precision Solutions
- Pencil Biosciences — Next Generation Genome Editing Tool
Boston Millennia Partners (BMP) has a long and successful history of growth capital investing on a national scope. Our Core Company Investment Strategy, combined with our international network of relationships and deep industry expertise, sets us apart from other investor groups and enables us to contribute meaningfully to our portfolio companies.The company focuses on investment opportunities within the healthcare and business services industries. Outsourcing and software as a service business companies are of particular interest for investment.Boston Millennia Partners' goal is to be supportive and effective investing partners, and establish productive relationships with its business partners that create long-term value.The company seeks to partner with entrepreneurs who share our goal of building enduring, large-scale businesses that result in personal fulfillment and superior financial returns. Over the past thirty years, it has implemented an investment approach that centers on active participation with our portfolio companies. Its goal is to be supportive and effective investing partners and establish productive relationships with its business partners that create long-term value.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Funding Round, Series C, Series B
- United States, Israel, Hungary
Portfolio highlights
- Korio — Korio is an IRT platform that focuses on industry compliance.Korio integrated the most recent IRT design intelligence into our solution to address the long-standing issues of operational inefficiencies, burdensome manual processes, and poor user experiences.
- S2N Health — We transform vast amounts of healthcare data into actionable business intelligence to accelerate market adoption and growth for medtech companies.
- KAID Health — KAID Health offers and specializes in artificial intelligence and natural language processing for healthcare organizations. KAID allows providers and payers to collaborate to achieve their individual clinical, operational, and financial goals, including revenue optimization and bending the cost-curve.
Portfolion is a CEE-focused multi-stage investor with a flexible fund structure that allows it to back companies from or before 1st client until the end of their journey. The fund manager has backed some of the CEE region’s most successful companies including SEON, Novakid, Tresorit, Packhelp, and Starschema.
Show more
Investment focus
- Software, Information Technology, Big Data
- Series A, Seed, Series B
- Hungary, Poland, United States
Portfolio highlights
- NORBr — Build your no-code payment stack with the best payment providers. One API to rule them all. Move faster. Go further.
- 4fizjo — 4fizjo.pl is a store offers premium sports and physiotherapy accessories for health and relaxation.
- Coding Giants — Put description here
Bonitás is more than an investor. Our team helps the brave founders to pursue their dreams and build extraordinary companies. We push because we respect. Partnering with Bonitás, founders can benefit from our unmatched network and gain experience in management support. Bonitás is proud that our backed companies also propel great causes.
Show more
Investment focus
- Information Technology, Education, Software
- Seed, Series A
- Hungary
Portfolio highlights
- Livlia — As Hungary’s first hybrid real estate service, portal, and ecosystem, Livlia’s goal is to revolutionize the Hungarian and the regional real estate market with their automatized working methods, modern solutions and professional real estate experts. The platform is launching today with the aim of digitalising and revolutionizing and the entire realestate industry.Ads optimization, developed price strategy, pre-identified customers, all of which can be traced on the platform which is complemented by a dedicated real estate expert. As a result of their modern and digitalised solutions and working methods, they thrive working for one of the most competitive success fees (1,5%) within the Hungarian real estate industry offering more, for less.
- MITE-CHEM KFT. — Manufacture of pesticides and other agrochemical products
- Gremon Systems — Digitalize your production with Gremon: discover the highest agricultural IT inventions in crop production, monitoring and evaluation of data. Be the first!
Budapest-based Euroventures is one of the longest-established and leading independent private equity and venture capital firms in Central Europe, with a proven ability to achieve international exits over two decades in a fast-changing environment.
It has advised or is advising five investment programmes totalling over €180m since 1989, with a focuson funding INNOVATION and GROWTH in Hungary and Central Europe.
The investors in Euroventures funds have been international institutional Investors.
Euroventures' nearly 50 current and former portfolio companies illustrate the commitment to provide steady support through the cycles of the regional and global economy.
Its professional team members have many decades of private equity / venture capital experience between them. Recent investments have targeted growing businesses with innovative technologies in the fields of medtech, big data, security, and IoT among others.
Euroventures has had an outstanding track record in supporting its portfolio companies entering global markets. As a result, it has delivered highly successful exits, including IPOs (Vienna, NASDAQ, NYSE) and several dozens of trade sales to international corporations.
Euroventures is a founding member of the Hungarian Venture Capital Association and complies with the conduct, governing principles and valuation/reporting guidelines of Invest Europe.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Series A, Funding Round, Seed
- Hungary, United Kingdom, United States
Portfolio highlights
- Antavo Enterprise Loyalty Cloud — Build the loyalty program of your dreams 10x faster, and run it on the most powerful loyalty platform with the best Workflow editor. All powered by AI.
- Daytrip — Daytrip is a platform for traveling with local drivers. It allows independent travelers to get the most out of their vacation by connecting them to local drivers, who drive them from one city to another with their own cars, discovering local sights and culture on the way.It gives travelers an opportunity to see otherwise unreachable countrysidesights, meet real locals and get to know local history, culture and current affairs first-hand. Daytrip is an entirely new approach to traveling, combining the comfort of package holidays with the flexibility of independent planning and authenticity of backpacking.
- Prefixbox — Prefixbox makes eCommerce search easy. Easy to integrate search modules increase conversion rates and online revenue within weeks.
Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Funding Round, Series A
- United States, Canada, Mexico
Portfolio highlights
- Qure AI — Qure ai is on a mission to provide accessible, affordable, & timely assistance to healthcare professionals
- Atropos Health — We create high-quality, personalized, real-world evidence in minutes and at scale, creating the trusted currency of value in healthcare
- Culmination Bio — Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more
Investment focus
- Software, Financial Services, Information Technology
- Series A, Series B, Seed
- United States, India, Singapore
Portfolio highlights
- Transaera — Transaera is developing a new class of affordable, energy-efficient, sustainable cooling systems and residential air conditioners.
- Treehouse — Treehouse is an electrical contractor for the 21st century. We offer a one-stop shop for EV charging, home batteries, and electrical services.
- ConnectDER — ConnectDER adapters let anyone connect solar panels or EV chargers to their home at a fraction of the typical time and cost....
Early Stage Venture Investments
Show more
Investment focus
- Health Care, Medical Device, Software
- Seed, Convertible Note, Series A
- United States, Canada, Hungary
Portfolio highlights
- Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Funding Round, Series A
- United Kingdom, United States, Hungary
Portfolio highlights
- Kuano — Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
- MGISS — Independently advising on the smarter use of Geospatial data, technology and the digital transformation of field operations.
- Workbuzz — Give your Everyday Heroes a voice with employee surveys. Our flexible and simple survey platform reaches all employees, wherever they are. Book a demo now!
SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).
Show more
Investment focus
- Biotechnology, Software, Health Care
- Series B, Funding Round, Series A
- France, United States, Germany
Portfolio highlights
- Augure — Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence inthe media and on social networks.The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies.Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.
- Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
- METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
Investors by industry
Consumer
Hardware
Climate
Proptech
Gaming
Google
Marketplace
Biotech
Impact
Community
Energy
FinTech
Artificial intelligence
Health Care
EdTech
Sustainability
Venture Capital
Real Estate
Retail
Clean Energy
Food and Beverage
B2B
Video Games
Web3
Photography
Education
Big Data
Finance
Financial Services
Payments
Beauty
Publishing
Infrastructure
Organic Food
Social Network
Social Media
Digital Media
Art
Medical
Android
Franchise
Mobile
Local
Music
Legal
Enterprise Software
eSports
Construction
Sports
Internet
Wellness
Email
Manufacturing
Recruiting
Mobile Advertising
Travel
Hospitality
Cannabis
Fitness
Biotechnology
Platforms
Wine And Spirits
Automotive
Social
Medical Device
Crowdfunding
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
Canada
United States
New Zealand
South Korea
Ireland
India
Australia
Africa
Sri Lanka
Europe
Middle East
China
Qatar
Vietnam
Armenia
Oceania
Brazil
Indonesia
Asia
South Africa
Spain
Saudi Arabia
Estonia
Japan
Bermuda
Gibraltar
Belarus
Singapore
Croatia
LATAM
Ethiopia
Belize
Liechtenstein
Egypt
Georgia
France
Denmark
Mauritius
Costa Rica
Greece
Lithuania
Czech Republic
Hungary
Ecuador
Italy
Faroe Islands
Chile
Ghana
Philippines
Finland
Bahrain
Algeria
Hong Kong
Mali
Belgium
Liberia
Jersey
Bulgaria
Malaysia
Barbados
Senegal
Uruguay
Israel
Puerto Rico
Sweden
Malta
El Salvador
Sierra Leone
Uganda
Lebanon
Slovenia
Norway
Taiwan
Myanmar
Togo
Seychelles
Morocco
Zambia
Venezuela
Tajikistan
Zimbabwe
Peru
Russian Federation
Nicaragua
Turkey
Tunisia
Uzbekistan
Thailand
Mexico
Rwanda
San Marino
Serbia
Tanzania
Panama
Ukraine
Kuwait
Portugal
Poland
Dominican Republic
United Arab Emirates
Bahamas
Iceland
Namibia
Nigeria
Azerbaijan
Jamaica
Iraq
Honduras
Isle of Man
Luxembourg
Bolivia
Jordan
Albania
Pakistan
Bangladesh
Argentina
Romania
Grenada
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cyprus
Latvia
Oman
Cameroon
Austria
Switzerland
Guatemala
Colombia
Marshall Islands
VC (Venture Capital) Funds in Hungary by industry
Transportation
Financial Services
Big Data
Web3
Payments
Education
Medical
Medical Device
Internet
Social Media
Manufacturing
Mobile
Android
Software
Sports
Automotive
Travel
Platforms
FinTech
Biotechnology
Consumer
Enterprise
Health Care
EdTech
Climate
SaaS
Marketplace
Hardware
Artificial intelligence
Gaming
Media (entertainment)
Mobile Apps
Biotech
Agriculture (agtech)
Cryptocurrency